Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
Poster
P285
ePoster
Rimegepant for the acute treatment of migraine – a phase 3, multicenter, open-label, long-term safety study in adults from China
Presented in
ePoster 04
Poster topics
New clinical developments in prophylactic and acute medications
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy